Pfizer Inc BDR (PFIZ34)

77.11 +2.32 (+3.10%)
Closed BRL Disclaimer

Pfizer Inc BDR Company Profile

Industry
Pharmaceuticals
Sector
Healthcare
Employees
78500
Equity Type
DRC
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zithromax, Vfend, and Panzyga brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Prevnar 13/Prevenar 13 (pediatric/adult), Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Pfizer-BioNTech COVID-19 vaccine brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa/Staquis brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; Arvinas, Inc.; and Syapse, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Contact Information
Address
New York,10017 United States
Phone
212 733 2323
Fax
-
Top Executives
Name
Age
Since
Title
Susan J. Hockfield 69 2020 Independent Director
Daniel R. Littman 68 2018 Independent Director
Albert Bourla 59 2016 Chairman of the Board & CEO
Suzanne M. Nora Johnson 64 2007 Independent Director
Ronald E. Blaylock 61 2017 Independent Director
James C. Smith 61 2014 Independent Director
Shantanu Narayen 57 2013 Lead Independent Director
Helen H. Hobbs 69 2011 Independent Director
Joseph J. Echevarria 64 2015 Independent Director
James Robert B. Quincey 56 2020 Independent Director
Scott Gottlieb 48 2019 Independent Director
Charles T. Hagel 75 0000 Member of Emerging Markets Advisory Board
Susan Desmond-Hellmann 64 2020 Independent Director
Clear All
0Selected
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.